These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2965621)

  • 1. [Recombinant vaccinia viruses--the basis of new vaccines].
    Vilcek S; Vrtiak OJ; Gdovinová A
    Cesk Epidemiol Mikrobiol Imunol; 1988 Mar; 37(2):73-9. PubMed ID: 2965621
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.
    Ramshaw IA; Andrew ME; Phillips SM; Boyle DB; Coupar BE
    Nature; 1987 Oct 8-14; 329(6139):545-6. PubMed ID: 3498904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New technology of vaccine production--international prospect of the development. Method and theory of production of vaccines by genetic engineering. b. Trials of development of recombinant vaccinia polyvaccines].
    Yasuda A; Kojima A
    Nihon Rinsho; 1987 Oct; 45(10):2342-8. PubMed ID: 3129603
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant vaccinia viruses as vaccines.
    Brown F; Schild GC; Ada GL
    Nature; 1986 Feb 13-19; 319(6054):549-50. PubMed ID: 3945343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of the gene responsible for formation of hemorrhage as a phenotypic marker in creating hybrid variations of vaccinia virus].
    Totmenin AV; Gashnikov PV; Shchelkunov SN; Sandakhchiev LS
    Dokl Akad Nauk SSSR; 1989; 305(5):1246-8. PubMed ID: 2752898
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccinia virus recombinants: potential vaccines.
    Mackett M
    Acta Trop Suppl; 1987 Jun; 12():94-7. PubMed ID: 3307346
    [No Abstract]   [Full Text] [Related]  

  • 8. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.
    Moss B
    Dev Biol Stand; 1994; 82():55-63. PubMed ID: 7958483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus recombinant vaccines for rinderpest.
    Yilma T
    Dev Biol Stand; 1995; 84():201-8. PubMed ID: 7796955
    [No Abstract]   [Full Text] [Related]  

  • 10. Applications of recombinant vaccinia virus for veterinary vaccines.
    Yilma T
    Dev Biol Stand; 1994; 82():201-9. PubMed ID: 7958475
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isolation of a recombinant vaccinia virus based on the LIVP strain inducing the surface antigen of the hepatitis B virus].
    Al'tshteĭn AD; Zakharova LG; Loparev VN; Pashvykina GV; Gorodetskiĭ SI
    Dokl Akad Nauk SSSR; 1985; 285(3):696-9. PubMed ID: 4092585
    [No Abstract]   [Full Text] [Related]  

  • 12. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
    Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
    Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant host range selection of vaccinia recombinants by rescue of an essential gene.
    Holzer GW; Gritschenberger W; Mayrhofer JA; Wieser V; Dorner F; Falkner FG
    Virology; 1998 Sep; 249(1):160-6. PubMed ID: 9740787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and simple method for determining the DNA sequences of fragments inserted into vaccinia virus.
    Sheng N; Zhang J; Whitton JL; McKee T
    Biotechniques; 1993 May; 14(5):781-4. PubMed ID: 8512703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].
    Li P; Hu Q; Sun Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):170-4. PubMed ID: 12569788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of recombinant vaccinia-rabies vaccine in veterinary use.
    Pastoret PP; Brochier B; Languet B; Duret C; Chappuis G; Desmettre P
    Dev Biol Stand; 1996; 87():245-9. PubMed ID: 8854024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and isolation of recombinant vaccinia virus using genetic markers.
    Lorenzo MM; Galindo I; Blasco R
    Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental inoculation of European red foxes with recombinant vaccinia virus expressing zona pellucida C proteins.
    Reubel GH; Beaton S; Venables D; Pekin J; Wright J; French N; Hardy CM
    Vaccine; 2005 Aug; 23(35):4417-26. PubMed ID: 15936853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen.
    Gu SY; Huang TM; Ruan L; Miao YH; Lu H; Chu CM; Motz M; Wolf H
    Dev Biol Stand; 1995; 84():171-7. PubMed ID: 7796951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.